Postpartum Hemorrhage (PPH) Treatment Devices

Global Market Trajectory & Analytics

MCP15984

EXECUTIVE ENGAGEMENTS

POOL

2709
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

488
Interactions with Platform & by Email

PARTICIPANTS

81
Unique # Participated

VALIDATIONS

23
Responses Validated*

COMPANIES

22
Responses Validated*
* Login for a full stack data experience

DATE

FEB 2021

TABLES

87

PAGES

194

EDITION

8

PRICE

USD 4950

CODE

MCP15984


COMPETITIVE METRICS

COMPANY

D S N T

% *

3RD Stone Design, Inc.

Alydia Health

Amsino International, Inc.

B. Braun Melsungen AG

Bactiguard

Becton, Dickinson and Company

Belmont Medical Technologies

Coloplast Group

Cook Medical, LLC

Cure Medical LLC

*Login to Participate & View Data Stacks
View 22 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Global Postpartum Hemorrhage (PPH) Treatment Devices Market to Reach $928.1 Million by 2026

Postpartum hemorrhage (PPH) accounts for majority of global maternal morbidity as well as mortality deaths. Emerging economies attributes for significantly higher number of causalities from obstetric hemorrhage as compared to developed countries. The market growth is poised to be driven by increasing cases of pregnancy-related complications like multiple pregnancies, large size of baby and upturned uterus that considerably increase the risk of developing postpartum bleeding or hemorrhage. The market is likely to also gain from increasing healthcare spending and ongoing efforts by various governments to raise awareness regarding these complications. The industry, which was already in a state of flux in the pre-COVID period with regards to financial robustness, suffered as demand for non-COVID healthcare services experienced an extra-ordinary drop impacting the cashflows of service providers in a major way. Maternity care and other related treatment areas have been relegated as a lesser priority. The scenario is likely revive in 2021 in lieu of vaccination programs being set out by governments across the world and also due to accumulation of patients seeking medical attention in the immediate term.

Amid the COVID-19 crisis, the global market for Postpartum Hemorrhage (PPH) Treatment Devices estimated at US$726.4 Million in the year 2020, is projected to reach a revised size of US$928.1 Million by 2026, growing at a CAGR of 4.2% over the analysis period. Uterine Balloon Tamponade, one of the segments analyzed in the report, is projected to grow at a 4% CAGR to reach US$427.9 Million by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Pneumatic Anti-Shock Garment (NASG) segment is readjusted to a revised 4.2% CAGR for the next 7-year period. This segment currently accounts for a 32.7% share of the global Postpartum Hemorrhage (PPH) Treatment Devices market. The Uterine balloon tamponade is the standard of care in healthcare facilities worldwide for treating PPH. It is most resorted to easily as it is highly effective and easily available and very affordable. The segment is anticipated to gain further from ongoing efforts by leading device makers to come up with innovative solutions. The non-pneumatic anti-shock garment (NASG), a low-technology based first-aid device, is used for treating hypovolemic shock. The device is used extensively to treat shock, stabilize, resuscitate, and prevent bleeding in women suffering from obstetric haemorrhage.

The U.S. Market is Estimated at $269.5 Million in 2021, While China is Forecast to Reach $114.6 Million by 2026

The Postpartum Hemorrhage (PPH) Treatment Devices market in the U.S. is estimated at US$269.5 Million in the year 2021. The country currently accounts for a 36.03% share in the global market. China, the world`s second largest economy, is forecast to reach an estimated market size of US$114.6 Million in the year 2026 trailing a CAGR of 5.9% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR while Rest of European market (as defined in the study) will reach US$121.5 Million by the end of the analysis period. Growth in the US market is set to be driven by rising cases of pregnancy-related complications and maternal mortality. The market is also poised to gain from the availability of sophisticated healthcare facilities, increasing awareness, easy access to treatment devices and high hospital delivery rates. The European market is estimated to display immense growth due to a sizeable population with the risk of medical conditions like severe PPH, multiple pregnancy, uterine fibromas, HELLP syndrome and anaemia. The regional market is driven by increasing frequency of these complications along government support to existing players serving the market. The Asia-Pacific market is likely to gain further from continuing efforts by governments to prevent maternal mortalities and ensure access to desired treatment for effective management during the third phase of labor. In addition, lack of expert caregivers, operating competences and blood-transfusion facilities in the region are anticipated to further drive the demand for PPH treatment devices.

Uniject Prefilled Injection System Segment to Reach $214.1 Million by 2026

Uniject Prefilled Injection System is a one-in-all auto-disposable drug delivery system for subcutaneous or intramuscular (IM) injections. This system allows one to fill a given drug dose in single amount precisely, while ensuring the delivery of correct drug amount and avoiding the discarding of the dose unnecessarily. By using this system, the burden is minimized on healthcare system, as it integrates the syringe and the drug into a single unit. In the global Uniject Prefilled Injection System segment, USA, Canada, Japan, China and Europe will drive the 4.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$130.4 Million in the year 2020 will reach a projected size of US$175.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$17.9 Million by the year 2026, while Latin America will expand at a 5.8% CAGR through the analysis period.

SELECT PLAYERS

3RD Stone Design, Inc.; Bactiguard AB; Becton, Dickinson, and Company; C. R. Bard, Inc; Cook Medical, Inc.; Alydia Health; Revmedx Inc.; Teleflex Incorporated; Utah Medical Products, Inc.

SEGMENTS

» Segment (Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG), Uniject Prefilled Injection System)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Brazil » Rest of Latin America » Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
2020 Marked as a Year of Disruption & Transformation
EXHIBIT 1: World Economic Growth Projections (Real GDP, Annual % Change) for 2019 to 2022
COVID-19 Pandemic Impact on Healthcare and Postpartum Hemorrhage Treatment Devices Market
Postpartum Haemorrhage - The Leading Cause of Maternal Death Globally
PPH: Management using PPH Treatment Devices
Rising Incidence of Postpartum Hemorrhage Give Special Thrust to Global Postpartum Hemorrhage Treatment Devices Market
Uterine Balloon Tamponades Lead the Global PPH Treatment Devices Market
US and Europe Account for Major Share of the Market
Competition
2. FOCUS ON SELECT PLAYERS
Recent Market Activity
3. MARKET TRENDS & DRIVERS
Increase in Birth Rate Offers Opportunities for Postpartum Hemorrhagic Treatment Devices Market
EXHIBIT: Global New Births (in Millions) per Annum by Geographic Region
Birth Statistics Across the World
Rise in Pregnancy Complications Drives Market Growth
Prevalence of Anaemia in Pregnant Women Bolsters Demand
The Millennials Reaching Child-Bearing Age Drive Healthy Market Growth
TABLE 3: Global Millennial Population by Region (2020E): Percentage Breakdown of Number of Millennials for North America, Europe, China & Japan, Latin America and Rest of World
EXHIBIT: Millennial Population as a Percentage (%) of Total Population in Developing Countries: 2020
Rising Working Women Population Increases the Risk of PPH
EXHIBIT: Top 10 Countries Worldwide with the Highest Proportion of Working Women in the Nation’s Women Population
Rising Obesity Incidence Spurs the Demand for PPH Treatment Devices
EXHIBIT: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P
New Advancements/Innovations in the PPH Treatment Devices Market
Alydia Health to Launch Device for Treating Patients Suffering from Postpartum Hemorrhage
PATH and Sinapi Biomedical Introduce Ellavi for Combating Postpartum Haemorrhage
PPH Butterfly
Alydia Health Announces FDA Clearance for its Jada® System
Advanced Uterine Tamponade Devices to Mitigate Postpartum Hemorrhage Complications
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Uterine Balloon Tamponade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Uterine Balloon Tamponade by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Uterine Balloon Tamponade by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Uniject Prefilled Injection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Uniject Prefilled Injection System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Uniject Prefilled Injection System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Non-Pneumatic Anti-Shock Garment (NASG) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Brazil and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Brazil and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Postpartum Hemorrhage (PPH) Treatment Devices by Segment - Percentage Breakdown of Value Sales for Uterine Balloon Tamponade, Non-Pneumatic Anti-Shock Garment (NASG) and Uniject Prefilled Injection System for the Years 2012, 2020 & 2027
Total Companies Profiled: 22

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com